substance p has been researched along with thromboxane a2 in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (12.50) | 18.7374 |
1990's | 18 (75.00) | 18.2507 |
2000's | 3 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, PJ; Giembycz, MA; Kroegel, C | 1 |
Nakamura, N; Onoue, H; Toda, N | 1 |
Russell, JA | 1 |
Hildebrandt, J; Lai, YL; Lamm, WJ | 1 |
Bund, SJ; Heagerty, AM; Oldham, AA | 1 |
Hull, AD; Pearce, WJ; White, CR | 1 |
Tesfamariam, B | 1 |
Bodelsson, G; Marsál, K; Stjernquist, M | 1 |
Kanda, M; Kurahashi, K; Nakamura, S; Shimizu, Y; Shirahase, H; Usui, H | 1 |
Bull, HA; Chowdhury, N; Cohen, J; Dowd, PM; Hothersall, J | 1 |
Aoki, H; Kanaide, H; Kobayashi, S; Kuroiwa, M; Nishimura, J | 1 |
Matsuda, H; Miyatake, K; Nagata, S; Ohmori, F; Uematsu, M | 1 |
Gecse, A; Kis, B; Mezei, Z; Telegdy, G | 1 |
Canet, E; Dacquet, C; Dhainaut, A; Félétou, M; Lonchampt, M; Martin, CA | 1 |
Bax, WA; Bos, E; Ferrari, MD; Maassen VanDenBrink, A; Saxena, PR; Zijlstra, FJ | 1 |
Bodelsson, M; Wallerstedt, SM | 1 |
Caddell, JL | 1 |
He, GW; Yang, CQ; Yang, JA | 1 |
Champion, HC; Kadowitz, PJ | 1 |
Rayner, SE; Van Helden, DF | 1 |
Kanda, M; Kurahashi, K; Murase, K; Nakamura, S; Shirahase, H | 1 |
Itoh, T; Kajikuri, J; Suzuki, Y; Suzumori, K | 1 |
Andoh, T | 1 |
Kanda, M; Kunishiro, K; Kurahashi, K; Miike, T; Shirahase, H | 1 |
2 review(s) available for substance p and thromboxane a2
Article | Year |
---|---|
Evidence for magnesium deficiency in the pathogenesis of bronchopulmonary dysplasia (BPD).
Topics: Animals; Bronchopulmonary Dysplasia; Chemokines; Endothelin-1; Free Radicals; Humans; Hydroxyeicosatetraenoic Acids; Immunoglobulins; Infant, Newborn; Infant, Very Low Birth Weight; Magnesium Deficiency; Nitric Oxide; Substance P; Thromboxane A2; Tumor Necrosis Factor-alpha | 1996 |
[Mechanisms of cutaneous itch: new itch mediators and enhancement factors produced by keratinocytes].
Topics: Animals; Autocrine Communication; Drug Design; Free Radicals; Histamine; Humans; Hydrogen Peroxide; Immunoglobulin E; Keratinocytes; Leukotriene B4; Mast Cells; Nitric Oxide; Pruritus; Receptors, IgG; Substance P; Thromboxane A2 | 2008 |
22 other study(ies) available for substance p and thromboxane a2
Article | Year |
---|---|
Characterization of eosinophil cell activation by peptides. Differential effects of substance P, melittin, and FMET-Leu-Phe.
Topics: Animals; Calcium; Cytoplasm; Eosinophils; Guinea Pigs; Kinetics; L-Lactate Dehydrogenase; Melitten; N-Formylmethionine Leucyl-Phenylalanine; Neurokinin A; Peritoneal Cavity; Peroxidases; Substance P; Superoxides; Thromboxane A2 | 1990 |
Endothelium-dependent and -independent responses to vasodilators of isolated dog cerebral arteries.
Topics: Animals; Calcimycin; Cerebral Arteries; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; In Vitro Techniques; Indomethacin; Male; Methylene Blue; Osmolar Concentration; Substance P; Thromboxane A2; Vasodilator Agents; Vasopressins | 1988 |
Substance P elicits thromboxane-induced contraction of canine pulmonary veins.
Topics: Animals; Dogs; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Pulmonary Veins; Substance P; Thromboxane A2; Thromboxanes | 1988 |
Factors affecting massive postmortem bronchoconstriction in guinea pig lungs.
Topics: Animals; Bronchi; Calcium; Capsaicin; Chromones; Constriction, Pathologic; Diethylcarbamazine; Guinea Pigs; Imidazoles; Male; Postmortem Changes; Pulmonary Circulation; SRS-A; Substance P; Thromboxane A2 | 1984 |
Influence of arterial diameter on vasomotor responses in the porcine coronary vasculature.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Arteries; Bradykinin; Coronary Circulation; Female; In Vitro Techniques; Male; Norepinephrine; Propranolol; Prostaglandin Endoperoxides, Synthetic; Substance P; Swine; Swine, Miniature; Thromboxane A2; Vasomotor System | 1994 |
Endothelium-derived relaxing factor and cyclic GMP-dependent vasorelaxation in human chorionic plate arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Arteries; Bradykinin; Calcimycin; Chorion; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Female; Histamine; Humans; Muscle Contraction; Muscle Relaxation; Nitric Oxide; Pregnancy; Prostaglandin Endoperoxides, Synthetic; Serotonin; Substance P; Thromboxane A2; Vasoconstrictor Agents; Vasodilation | 1994 |
Thrombin receptor-mediated vascular relaxation differentiated by a receptor antagonist and desensitization.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amino Acid Sequence; Animals; Bradykinin; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Kinetics; Molecular Sequence Data; Muscle Relaxation; Muscle, Smooth, Vascular; Oligopeptides; Peptide Fragments; Prostaglandin Endoperoxides, Synthetic; Receptors, Thrombin; Serotonin; Substance P; Swine; Thrombin; Thromboxane A2; Vasoconstrictor Agents | 1994 |
Reduced contractile effect of endothelin-1 and noradrenalin in human umbilical artery from pregnancies with abnormal umbilical artery flow velocity waveforms.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Blood Flow Velocity; Dose-Response Relationship, Drug; Endothelins; Epoprostenol; Female; Fetal Growth Retardation; Hemodynamics; Humans; Muscle, Smooth, Vascular; Norepinephrine; Pre-Eclampsia; Pregnancy; Prostaglandin Endoperoxides, Synthetic; Regional Blood Flow; Serotonin; Substance P; Thromboxane A2; Ultrasonography, Doppler; Umbilical Arteries; Vasoconstriction; Vasoconstrictor Agents | 1995 |
Endothelium-dependent contraction in intrapulmonary arteries: mediation by endothelial NK1 receptors and TXA2.
Topics: Animals; Cyclooxygenase Inhibitors; Endothelium, Vascular; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Neurokinin A; Neurokinin B; Neurokinin-1 Receptor Antagonists; Rabbits; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Substance P; Tachykinins; Thromboxane A2; Thromboxane-A Synthase | 1995 |
Neuropeptides induce release of nitric oxide from human dermal microvascular endothelial cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Calcitonin Gene-Related Peptide; Cells, Cultured; Endothelium, Vascular; Humans; Microcirculation; Nitric Oxide; Nitric Oxide Synthase; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Skin; Substance P; Thromboxane A2 | 1996 |
Mechanism of endothelium-dependent relaxation induced by substance P in the coronary artery of the pig.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Analysis of Variance; Animals; Arginine; Biological Factors; Coronary Vessels; Endothelium, Vascular; Fluorometry; Fura-2; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitroarginine; Prostaglandin Endoperoxides, Synthetic; Substance P; Swine; Thromboxane A2; Vasoconstrictor Agents | 1995 |
Different modes of sensory neuropeptides and nitric oxide involvement in relaxation of guinea-pig vessels.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arginine; Calcitonin Gene-Related Peptide; Capsaicin; Dipeptides; Dose-Response Relationship, Drug; Electric Stimulation; Female; Guinea Pigs; In Vitro Techniques; Indoles; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Neurons, Afferent; Neuropeptides; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prostaglandin Endoperoxides, Synthetic; Receptors, Neurotransmitter; Substance P; Thromboxane A2; Vasoconstrictor Agents | 1995 |
The effect of bradykinin and substance P on the arachidonate cascade of platelets.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Arachidonic Acid; Blood Platelets; Bradykinin; Dose-Response Relationship, Drug; Eicosanoids; In Vitro Techniques; Male; Platelet Activation; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptors, Bradykinin; Receptors, Neurokinin-1; Substance P; Thromboxane A2 | 1996 |
In vitro pharmacological effects of S 12370 (2-[4-benzhydryloxypiperidinoethyl]isoxindole; an antibronchoconstrictor agent) in normal and sensitized tissue.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Arachidonic Acid; Benzhydryl Compounds; Binding, Competitive; Electric Stimulation; Guinea Pigs; Heart; Histamine; Leukotriene D4; Lung; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Ovalbumin; Oxindoles; Prostaglandin Endoperoxides, Synthetic; Rats; Receptors, Adrenergic, beta; Serotonin; Substance P; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Arteries; Child; Child, Preschool; Coronary Vessels; Female; Humans; In Vitro Techniques; Infant; Male; Middle Aged; Potassium; Prostaglandin Endoperoxides, Synthetic; Substance P; Sumatriptan; Thromboxane A2; Vasoconstrictor Agents | 1996 |
Endothelium-dependent relaxation by substance P in human isolated omental arteries and veins: relative contribution of prostanoids, nitric oxide and hyperpolarization.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adult; Aged; Aged, 80 and over; Arteries; Electrophysiology; Endothelium, Vascular; Enzyme Inhibitors; Humans; In Vitro Techniques; Middle Aged; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Substance P; Tetraethylammonium Compounds; Thromboxane A2; Vasoconstrictor Agents; Veins | 1997 |
Depolarizing cardiac arrest and endothelium-derived hyperpolarizing factor-mediated hyperpolarization and relaxation in coronary arteries: the effect and mechanism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Biological Factors; Coronary Vessels; Endothelium, Vascular; Female; Heart; Heart Arrest, Induced; Hyperkalemia; In Vitro Techniques; Indomethacin; Male; Membrane Potentials; Muscle Relaxation; Muscle, Smooth, Vascular; Organ Preservation Solutions; Potassium Channels; Prostaglandin Endoperoxides, Synthetic; Substance P; Swine; Thromboxane A2; Vasoconstrictor Agents | 1997 |
Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Albuterol; Alprostadil; Analysis of Variance; Angiotensin II; Animals; Benzopyrans; Blood Pressure; Bradykinin; Cats; Cromakalim; Endothelium, Vascular; Female; Glyburide; Heart Rate; Hindlimb; Hydrazines; Isradipine; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitrogen Oxides; Nitroprusside; Norepinephrine; Penicillamine; Prostaglandin Endoperoxides, Synthetic; Pyrroles; S-Nitroso-N-Acetylpenicillamine; Substance P; Tetraethylammonium; Tetraethylammonium Compounds; Thromboxane A2; Vasoactive Intestinal Peptide; Vasodilation; Vasodilator Agents | 1997 |
Evidence that the substance P-induced enhancement of pacemaking in lymphatics of the guinea-pig mesentery occurs through endothelial release of thromboxane A2.
Topics: Androstanes; Animals; Arachidonic Acid; Benzimidazoles; Calcium; Dose-Response Relationship, Drug; Endothelins; Endothelium, Vascular; Guinea Pigs; In Vitro Techniques; Indomethacin; Lymphatic System; Mesentery; Pertussis Toxin; Phospholipases A; Phospholipases A2; Substance P; Thromboxane A2; Virulence Factors, Bordetella | 1997 |
Endothelium-dependent contraction induced by substance P in canine cerebral arteries: involvement of NK1 receptors and thromboxane A2.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cerebral Arteries; Cyclooxygenase Inhibitors; Dogs; Endothelium, Vascular; Female; In Vitro Techniques; Male; Neurokinin-1 Receptor Antagonists; Papaverine; Piperidines; Quinuclidines; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Substance P; Tachykinins; Thromboxane A2; Thromboxane-A Synthase; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1999 |
Mechanisms underlying the reduced endothelium-dependent relaxation in human omental resistance artery in pre-eclampsia.
Topics: Adult; Benzimidazoles; Bradykinin; Calcium; Calcium Channel Agonists; Cyclic GMP; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Omentum; Potassium; Pre-Eclampsia; Pregnancy; Substance P; Thromboxane A2; Vasodilation | 2000 |
Regional heterogeneity of substance P-induced endothelium-dependent contraction, relaxation, and -independent contraction in rabbit pulmonary arteries.
Topics: Animals; Endothelium, Vascular; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Pulmonary Artery; Rabbits; Receptors, Neurokinin-2; Substance P; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2008 |